Literature DB >> 28390144

Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.

Atsushi Ono1,2, Nicolas Goossens1,3, Richard S Finn4, Warren N Schmidt5, Swan N Thung6, Gene Y Im1, Yujin Hoshida1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28390144      PMCID： PMC5605396          DOI： 10.1002/hep.29203

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  3 in total

1.  A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.

Authors:  Lindsay Y King; Claudia Canasto-Chibuque; Kara B Johnson; Shun Yip; Xintong Chen; Kensuke Kojima; Manjeet Deshmukh; Anu Venkatesh; Poh Seng Tan; Xiaochen Sun; Augusto Villanueva; Angelo Sangiovanni; Venugopalan Nair; Milind Mahajan; Masahiro Kobayashi; Hiromitsu Kumada; Massimo Iavarone; Massimo Colombo; Maria Isabel Fiel; Scott L Friedman; Josep M Llovet; Raymond T Chung; Yujin Hoshida
Journal:  Gut       Date:  2014-08-20       Impact factor: 23.059

2.  Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.

Authors:  Shigeki Nakagawa; Lan Wei; Won Min Song; Takaaki Higashi; Sarani Ghoshal; Rosa S Kim; C Billie Bian; Suguru Yamada; Xiaochen Sun; Anu Venkatesh; Nicolas Goossens; Gretchen Bain; Gregory Y Lauwers; Anna P Koh; Mohamed El-Abtah; Noor B Ahmad; Hiroki Hoshida; Derek J Erstad; Ganesh Gunasekaran; Youngmin Lee; Ming-Lung Yu; Wan-Long Chuang; Chia-Yen Dai; Masahiro Kobayashi; Hiromitsu Kumada; Toru Beppu; Hideo Baba; Milind Mahajan; Venugopalan D Nair; Michael Lanuti; Augusto Villanueva; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Josep M Llovet; Aravind Subramanian; Andrew M Tager; Scott L Friedman; Thomas F Baumert; Myron E Schwarz; Raymond T Chung; Kenneth K Tanabe; Bin Zhang; Bryan C Fuchs; Yujin Hoshida
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 38.585

Review 3.  Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.

Authors:  Thomas F Baumert; Frank Jühling; Atsushi Ono; Yujin Hoshida
Journal:  BMC Med       Date:  2017-03-14       Impact factor: 11.150
  3 in total
  18 in total

1.  Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.

Authors:  Naoto Fujiwara; Naoto Kubota; Emilie Crouchet; Bhuvaneswari Koneru; Cesia A Marquez; Arun K Jajoriya; Gayatri Panda; Tongqi Qian; Shijia Zhu; Nicolas Goossens; Xiaochen Wang; Shuang Liang; Zhenyu Zhong; Sara Lewis; Bachir Taouli; Myron E Schwartz; Maria Isabel Fiel; Amit G Singal; Jorge A Marrero; Austin J Fobar; Neehar D Parikh; Indu Raman; Quan-Zhen Li; Masataka Taguri; Atsushi Ono; Hiroshi Aikata; Takashi Nakahara; Hayato Nakagawa; Yuki Matsushita; Ryosuke Tateishi; Kazuhiko Koike; Masahiro Kobayashi; Takaaki Higashi; Shigeki Nakagawa; Yo-Ichi Yamashita; Toru Beppu; Hideo Baba; Hiromitsu Kumada; Kazuaki Chayama; Thomas F Baumert; Yujin Hoshida
Journal:  Sci Transl Med       Date:  2022-06-22       Impact factor: 19.319

Review 2.  Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.

Authors:  Don C Rockey; Scott L Friedman
Journal:  Gastroenterology       Date:  2021-01-30       Impact factor: 22.682

3.  Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis.

Authors:  Naoto Fujiwara; Yujin Hoshida
Journal:  Semin Liver Dis       Date:  2019-03-25       Impact factor: 6.512

Review 4.  Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases.

Authors:  Naoto Fujiwara; Tongqi Qian; Bhuvaneswari Koneru; Yujin Hoshida
Journal:  Hepatol Res       Date:  2020-05-15       Impact factor: 4.942

5.  Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.

Authors:  Tongqi Qian; Naoto Fujiwara; Bhuvaneswari Koneru; Atsushi Ono; Naoto Kubota; Arun K Jajoriya; Matthew G Tung; Emilie Crouchet; Won-Min Song; Cesia Ammi Marquez; Gayatri Panda; Ayaka Hoshida; Indu Raman; Quan-Zhen Li; Cheryl Lewis; Adam Yopp; Nicole E Rich; Amit G Singal; Shigeki Nakagawa; Nicolas Goossens; Takaaki Higashi; Anna P Koh; C Billie Bian; Hiroki Hoshida; Parissa Tabrizian; Ganesh Gunasekaran; Sander Florman; Myron E Schwarz; Spiros P Hiotis; Takashi Nakahara; Hiroshi Aikata; Eisuke Murakami; Toru Beppu; Hideo Baba; Sangeeta Bhatia; Masahiro Kobayashi; Hiromitsu Kumada; Austin J Fobar; Neehar D Parikh; Jorge A Marrero; Steve Hategekimana Rwema; Venugopalan Nair; Manishkumar Patel; Seunghee Kim-Schulze; Kathleen Corey; Jacqueline G O'Leary; Goran B Klintmalm; David L Thomas; Mohammed Dibas; Gerardo Rodriguez; Bin Zhang; Scott L Friedman; Thomas F Baumert; Bryan C Fuchs; Kazuaki Chayama; Shijia Zhu; Raymond T Chung; Yujin Hoshida
Journal:  Gastroenterology       Date:  2021-12-22       Impact factor: 33.883

6.  Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma.

Authors:  Naoki Umezaki; Shigeki Nakagawa; Yo-Ichi Yamashita; Yuki Kitano; Kota Arima; Tatsunori Miyata; Yukiharu Hiyoshi; Hirohisa Okabe; Hidetoshi Nitta; Hiromitsu Hayashi; Katsunori Imai; Akira Chikamoto; Hideo Baba
Journal:  Cancer Sci       Date:  2019-04-18       Impact factor: 6.716

Review 7.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.

Authors:  Naoto Fujiwara; Scott L Friedman; Nicolas Goossens; Yujin Hoshida
Journal:  J Hepatol       Date:  2017-10-06       Impact factor: 30.083

8.  A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis.

Authors:  Naoto Fujiwara; Masahiro Kobayashi; Austin J Fobar; Ayaka Hoshida; Cesia A Marquez; Bhuvaneswari Koneru; Gayatri Panda; Masataka Taguri; Tongqi Qian; Indu Raman; Quan-Zhen Li; Hiroki Hoshida; Hitomi Sezaki; Hiromitsu Kumada; Ryosuke Tateishi; Takeshi Yokoo; Adam C Yopp; Raymond T Chung; Bryan C Fuchs; Thomas F Baumert; Jorge A Marrero; Neehar D Parikh; Shijia Zhu; Amit G Singal; Yujin Hoshida
Journal:  Med (N Y)       Date:  2021-04-21

Review 9.  Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.

Authors:  Maria Guarino; Anna Sessa; Valentina Cossiga; Federica Morando; Nicola Caporaso; Filomena Morisco
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

Review 10.  Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents.

Authors:  Marco Sanduzzi-Zamparelli; Loreto Boix; Cassia Leal; María Reig
Journal:  Viruses       Date:  2019-05-01       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.